Cost-Effectiveness Analysis of Three Therapeutic Schemes for Lower Respiratory Tract Infection / 中国药房
China Pharmacy
;
(12)2007.
Article
in Chinese
| WPRIM
| ID: wpr-529808
ABSTRACT
0.05);the cost-effectiveness ratios were 768.31,812.14 and 457.98,respectively.CONCLUSION:
Scheme C was proved to be the best therapeutic regime.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Health economic evaluation
Language:
Chinese
Journal:
China Pharmacy
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS